1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year.
Syneron Medical's 1-Year ROIIC % for the quarter that ended in Mar. 2017 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Syneron Medical's 1-Year ROIIC % or its related term are showing as below:
ELOS's 1-Year ROIIC % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.98 * Ranked among companies with meaningful 1-Year ROIIC % only.
Syneron Medical 1-Year ROIIC % Historical Data
The historical data trend for Syneron Medical's 1-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Syneron Medical's 1-Year ROIIC %
For the Medical Devices subindustry, Syneron Medical's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syneron Medical's 1-Year ROIIC % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Syneron Medical's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Syneron Medical's 1-Year ROIIC % falls into.
Syneron Medical 1-Year ROIIC % Calculation
Syneron Medical's 1-Year ROIIC % for the quarter that ended in Mar. 2017 is calculated as:
1-Year ROIIC %
=
1-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
1-Year Incremental Invested Capital
=
( -2.874 (Mar. 2017) - -5.1211 (Mar. 2016) )
/
( 171.968 (Mar. 2017) - 155.478 (Mar. 2016) )
=
2.2471
/
16.49
=
13.63%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Syneron Medical (NAS:ELOS) 1-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Syneron Medical 1-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Syneron Medical's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Syneron Medical (Syneron Medical) Business Description
Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments. The Company's products, which it sells mainly to physicians and other practitioners, target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis and topical skin brightening products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELOS has been successfully added to your 